Leadership Team

David Venables, PhD

Chief Executive Officer

Former President of AskBio Europe, CEO at Synpromics, Anatara Lifesciences and Ark Therapeutics. Founding leadership team NightStar Therapeutics. Honorary Professor, Edinburgh University.​

Tim Allsopp, PhD

Chief Technology Officer

 Former coordinator of the European Stem Cell Bank, Senior Research Fellow at Pfizer, and Chief Science Officer of Stem Cell Sciences plc.

Vlad Seitan, PhD

Chief Scientific Officer

 Former Group Leader at King’s College London, Department of Medical and Molecular Genetics. Extensive expertise in gene editing and RNAi technology research.

Elsy Boglioli

Chief Strategy Officer

Former Partner at the Boston Consulting Group, former COO at Cellectis. Chair Treefrog Therapeutics, Non-exec board member Gensight, 

Ali Elsley

Finance Director

 Former Financial Controller and Company Secretary Acacia Pharma Group, Senior Audit Manager PwC.

Tom Payne, PhD

Chief Operating Officer

 Former CSO at Oxgene, multiple research management roles at Cellinta, Lonza, Novozymes, including extensive expertise in the gene therapy and gene editing sector. 

Kamila Bailey

HR Director

Former VP People at Tropic Biosciences, former HR Leader at Horizon Discovery (now Reevity), and United Nations Environment Programme.